Dare Bioscience earnings were -$7.2M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest DARE earnings report on Jun 30, 2024 announced Q2 2024 earnings of $12.9M, down 291.1% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, DARE reported annual earnings of -$30.2M, with -2.5% growth. The next DARE earnings date is Nov 7, 2024.
What were Dare Bioscience's earnings last quarter?
On DARE's earnings call on Invalid Date, Dare Bioscience (NASDAQ: DARE) reported Q2 2024 earnings per share (EPS) of $1.53, up 225.41% year over year. Total DARE earnings for the quarter were $12.91 million. In the same quarter last year, Dare Bioscience's earnings per share (EPS) was -$1.22.
The next DARE earnings call is Invalid Date. Add DARE to your watchlist to be reminded of Dare Bioscience's next earnings date.
Is Dare Bioscience profitable or losing money?
As of the last Dare Bioscience earnings report, Dare Bioscience is currently losing money. Dare Bioscience's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$7.20 million, a 81.89% decrease year over year.
What was DARE's earnings growth in the past year?
As of Dare Bioscience's earnings date in Invalid Date, Dare Bioscience's earnings has grown year over year. DARE earnings in the past year totalled -$7.20 million.
What are Dare Bioscience's earnings expectations?
The current EPS estimate for Dare Bioscience's earnings report in Invalid Date is -$0.73.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.